Skip to main content
Equibles
VATE logo

VATE · INNOVATE Corp.

Track VATE — free

Use VATE with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about VATE

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$7.43 -0.13 (-1.72%)
Going-concern doubt — flagged Aug 6, 2026

Substantial doubt about the company's ability to continue as a going concern.

“However, as of the date of these financial statements, there is substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued. The principal conditions leading to this conclusion are the upcoming maturities of the Company's debt obligations.”
View the 10-Q filed Aug 6, 2026
Market Cap
$108.59M
Shares
13.64M

INNOVATE Corp. Earnings Call Transcripts

Every quarterly earnings call for INNOVATE Corp. (VATE) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲7.1% $423.00M −$5.40M '22 Q3 22-11-02 ▲3.7% $409.30M −$5.70M '22 Q4 23-03-14 ▼23% $317.90M −$9.00M '23 Q1 23-05-10 ▼6% $368.80M −$9.90M '23 Q2 23-08-09 ▼11.3% $375.30M −$7.00M '23 Q3 23-11-09 ▼11.8% $361.00M −$9.30M '23 Q4 24-03-04 ▼0.8% $315.20M −$17.40M '24 Q1 24-05-07 ▼15.1% $313.10M $14.40M '24 Q2 24-08-07 ▼35.5% $242.20M −$15.00M '24 Q3 24-11-06 ▼34.5% $236.60M −$16.60M '24 Q4 25-03-31 ▼13% $274.20M −$24.50M '25 Q1 25-05-06 ▼22.7% $242.00M −$19.80M '25 Q2 25-08-05 ▲43.3% $347.10M −$8.90M '25 Q3 25-11-12 ▲61.7% $382.70M −$7.40M '25 Q4 26-03-26 ▲33% $364.80M −$16.80M '26 Q1 26-05-14 LATEST ▲74.2% $421.60M $10.70M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
INNOVATE Corp. Q2 FY2026 Earnings Call
Positive tone Life Sciences / MediBeacon commercialization Infrastructure / DBMG performance Broadcasting refinancing and sale
Revenue
$421.60M
▲ 74.2% YoY
Diluted EPS
$0.71
Gross margin
18.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-14
INNOVATE Corp. Q1 FY2026 Earnings Call
Positive tone Infrastructure / DBM Global Backlog and Execution R2 Global Demand and Capital Needs MediBeacon Regulatory and Clinical Progress
Revenue
$364.80M
▲ 33% YoY
Diluted EPS
$-1.29
Gross margin
14.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-26
INNOVATE Corp. Q4 FY2025 Earnings Call
Revenue
$382.70M*
▲ 61.7% YoY
Gross margin
15.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
INNOVATE Corp. Q3 FY2025 Earnings Call
Positive tone DBM Global backlog and project awards Strategic alternatives and divestitures Capital structure, debt and liquidity
Revenue
$347.10M
▲ 43.3% YoY
Diluted EPS
$-0.71
Gross margin
14.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
INNOVATE Corp. Q2 FY2025 Earnings Call
Positive tone R2/Glacial Skin growth Refinancing and debt management Infrastructure/DBM Global backlog and margins
Revenue
$242.00M
▼ 22.7% YoY
Diluted EPS
$-1.67
▼ 262.1% YoY
Gross margin
18.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
INNOVATE Corp. Q1 FY2025 Earnings Call
Positive tone Revenue decline and net loss DBM Global / Infrastructure backlog and margins Liquidity and cash decline
Revenue
$274.20M
▼ 13% YoY
Diluted EPS
$-1.89
Gross margin
16.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
INNOVATE Corp. Q4 FY2024 Earnings Call
Revenue
$236.60M*
▼ 34.5% YoY
Gross margin
19.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-06
INNOVATE Corp. Q3 FY2024 Earnings Call
Positive tone DBM Global / Infrastructure results Spectrum profitability improvement R2 / Glacial Life Sciences growth
Revenue
$242.20M
▼ 35.5% YoY
Diluted EPS
$-1.18
Gross margin
19.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
INNOVATE Corp. Q2 FY2024 Earnings Call
Positive tone DBMG backlog and bidding MediBeacon FDA review Capital structure and refinancing
Revenue
$313.10M
▼ 15.1% YoY
Diluted EPS
$1.03
Gross margin
21.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
INNOVATE Corp. Q1 FY2024 Earnings Call
Positive tone Infrastructure / DBM Global performance MediBeacon FDA approval process Spectrum Networks and broadcasting
Revenue
$315.20M
▼ 0.8% YoY
Diluted EPS
$-2.21
Gross margin
15.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-04
INNOVATE Corp. Q4 FY2023 Earnings Call
Positive tone DBM Global / Infrastructure backlog and outlook MediBeacon FDA review Capital structure and liquidity
Revenue
$361.00M*
▼ 11.8% YoY
Gross margin
16.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
INNOVATE Corp. Q3 FY2023 Earnings Call
Revenue
$375.30M
▼ 11.3% YoY
Diluted EPS
$-0.93
Gross margin
15.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
INNOVATE Corp. Q2 FY2023 Earnings Call
Revenue
$368.80M
▼ 6% YoY
Diluted EPS
$-1.30
Gross margin
14.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
INNOVATE Corp. Q1 FY2023 Earnings Call
Revenue
$317.90M
▼ 23% YoY
Diluted EPS
$-1.30
Gross margin
13.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-14
INNOVATE Corp. Q4 FY2022 Earnings Call
Revenue
$409.30M*
▲ 3.7% YoY
Gross margin
15.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-02
INNOVATE Corp. Q3 FY2022 Earnings Call
Revenue
$423.00M
▲ 7.1% YoY
Diluted EPS
$-0.90
Gross margin
13.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
INNOVATE Corp. Q2 FY2022 Earnings Call
Revenue
$392.20M
▲ 60.9% YoY
Diluted EPS
$-1.80
Gross margin
12.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
INNOVATE Corp. Q1 FY2022 Earnings Call
Revenue
$412.80M
▲ 140.3% YoY
Diluted EPS
$-1.80
▼ 220% YoY
Gross margin
12.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-09
INNOVATE Corp. Q4 FY2021 Earnings Call
Revenue
$394.80M*
▲ 121.8% YoY
Gross margin
15.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
INNOVATE Corp. Q3 FY2021 Earnings Call
Revenue
$394.80M
▲ 131.6% YoY
Diluted EPS
$-27.50
Gross margin
14.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-06
INNOVATE Corp. Q2 FY2021 Earnings Call
Revenue
$243.80M
▲ 34.1% YoY
Diluted EPS
$-3.10
▼ 224% YoY
Gross margin
14.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-07
INNOVATE Corp. Q1 FY2021 Earnings Call
Revenue
$171.80M
▼ 7.9% YoY
Diluted EPS
$1.50
Gross margin
17.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-10
INNOVATE Corp. Q4 FY2020 Earnings Call
Revenue
$178.00M*
Gross margin
20.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
INNOVATE Corp. Q3 FY2020 Earnings Call
Revenue
$170.50M
▼ 60.1% YoY
Diluted EPS
$-3.70
Gross margin
18.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
INNOVATE Corp. Q2 FY2020 Earnings Call
Revenue
$181.80M
▼ 62.1% YoY
Diluted EPS
$2.50
▲ 108.3% YoY
Gross margin
16.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
INNOVATE Corp. Q1 FY2020 Earnings Call
Revenue
$186.60M
▼ 58.4% YoY
Diluted EPS
$-18.20
Gross margin
16.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-16
INNOVATE Corp. Q4 FY2019 Earnings Call
Revenue
$*
▼ 153.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 earnings calls
Key facts CIK 1006837 CUSIP 45784J303 13F (30d) 48 filings 48 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)